Cell cycle restriction is more important than apoptosis induction for RASSF1A protein tumor suppression

Howard Donninger1, Jennifer A Clark1, Megan K Monaghan1

  • 1From the Departments of Medicine.

Insights

Ras association domain family protein 1A (RASSF1A) is a tumor suppressor. Its ability to regulate microtubules, not apoptosis, is key to suppressing tumors by controlling cell cycle arrest.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ras association domain family protein 1A (RASSF1A) is frequently inactivated in human cancers.
  • RASSF1A regulates apoptosis and cell cycle, potentially through microtubule interactions.

Purpose of the Study:

  • To determine whether RASSF1A's tumor suppressor function relies on apoptosis induction or microtubule regulation.
  • To investigate the role of RASSF1A in cell cycle control and tumorigenesis.

Main Methods:

  • Identified a conserved motif essential for RASSF1A binding to microtubule-associated proteins.
  • Generated a RASSF1A mutant with impaired microtubule binding but intact apoptotic properties.
  • Compared the tumor suppressor functions of wild-type RASSF1A and the mutant.

Main Results:

  • The RASSF1A mutant retained proapoptotic properties but lost the ability to bind microtubules.
  • The mutant RASSF1A failed to induce cell cycle arrest or suppress tumorigenesis.
  • Wild-type RASSF1A demonstrated cell cycle arrest and tumor suppression capabilities.

Conclusions:

  • RASSF1A's tumor suppressor function is primarily mediated by its effects on the cell cycle and microtubules, not its apoptotic activity.
  • Microtubule regulation is crucial for RASSF1A's role in preventing cancer development.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K